LH — Laboratory of America Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- $16.95bn
- $21.57bn
- $12.16bn
- 88
- 45
- 80
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 825 | 1,557 | 2,380 | 1,281 | 419 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 308 | 858 | 325 | 627 | 771 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -294 | -857 | -264 | -603 | -362 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 1,445 | 2,135 | 3,110 | 1,956 | 1,328 |
Capital Expenditures | -400 | -382 | -460 | -482 | -454 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -883 | -262 | -424 | -1,170 | -718 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,283 | -643 | -885 | -1,652 | -1,172 |
Financing Cash Flow Items | -77.5 | -61.1 | -74 | -77.6 | 1,440 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -253 | -517 | -2,066 | -1,322 | -59.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -89.3 | 983 | 152 | -1,043 | 107 |